Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KTLA-TV Los Angeles· 7 hours agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Quartz· 9 hours agoThe U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 7 hours agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 11 hours agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Benzinga via Yahoo Finance· 11 hours agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on...
USPTO Issues Guidance on Use of AI-Based Tools
The National Law Review· 7 hours agoOn April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 10 hours agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...